90 related articles for article (PubMed ID: 23377192)
1. Cytotoxicity of chemotherapeutic agents in glyceraldehyde-3-phosphate dehydrogenase-depleted human lung carcinoma A549 cells with the accelerated senescence phenotype.
Phadke M; Krynetskaia N; Krynetskiy E
Anticancer Drugs; 2013 Apr; 24(4):366-74. PubMed ID: 23377192
[TBL] [Abstract][Full Text] [Related]
2. Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.
Phadke MS; Krynetskaia NF; Mishra AK; Krynetskiy E
J Pharmacol Exp Ther; 2009 Oct; 331(1):77-86. PubMed ID: 19628630
[TBL] [Abstract][Full Text] [Related]
3. Accelerated cellular senescence phenotype of GAPDH-depleted human lung carcinoma cells.
Phadke M; Krynetskaia N; Mishra A; Krynetskiy E
Biochem Biophys Res Commun; 2011 Jul; 411(2):409-15. PubMed ID: 21749859
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
[TBL] [Abstract][Full Text] [Related]
5. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
[TBL] [Abstract][Full Text] [Related]
6. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.
Roberson RS; Kussick SJ; Vallieres E; Chen SY; Wu DY
Cancer Res; 2005 Apr; 65(7):2795-803. PubMed ID: 15805280
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target.
Krasnov GS; Dmitriev AA; Snezhkina AV; Kudryavtseva AV
Expert Opin Ther Targets; 2013 Jun; 17(6):681-93. PubMed ID: 23445303
[TBL] [Abstract][Full Text] [Related]
9. B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cells.
Cheng MH; Yang YC; Wong YH; Chen TR; Lee CY; Yang CC; Chen SH; Yang IN; Yang YS; Huang HS; Yang CY; Huang MS; Chiu HF
Anticancer Drugs; 2012 Feb; 23(2):191-9. PubMed ID: 22008852
[TBL] [Abstract][Full Text] [Related]
10. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
11. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
[TBL] [Abstract][Full Text] [Related]
12. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
13. Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase.
Sukhanov S; Higashi Y; Shai SY; Itabe H; Ono K; Parthasarathy S; Delafontaine P
Circ Res; 2006 Jul; 99(2):191-200. PubMed ID: 16778134
[TBL] [Abstract][Full Text] [Related]
14. Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity.
Kulesza DW; Carré T; Chouaib S; Kaminska B
Exp Cell Res; 2013 Feb; 319(4):506-16. PubMed ID: 23149124
[TBL] [Abstract][Full Text] [Related]
15. Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation.
Demarse NA; Ponnusamy S; Spicer EK; Apohan E; Baatz JE; Ogretmen B; Davies C
J Mol Biol; 2009 Dec; 394(4):789-803. PubMed ID: 19800890
[TBL] [Abstract][Full Text] [Related]
16. The mitochondrial carrier SLC25A10 regulates cancer cell growth.
Zhou X; Paredes JA; Krishnan S; Curbo S; Karlsson A
Oncotarget; 2015 Apr; 6(11):9271-83. PubMed ID: 25797253
[TBL] [Abstract][Full Text] [Related]
17. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
18. Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects.
Li B; Torossian A; Sun Y; Du R; Dicker AP; Lu B
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e525-31. PubMed ID: 22836051
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 in cancer and normal tissue cells as a prediction marker of response to 5-fluorouracil.
Sasaki M; Kumazaki T; Tanimoto K; Nishiyama M
Int J Oncol; 2003 Jan; 22(1):181-6. PubMed ID: 12469202
[TBL] [Abstract][Full Text] [Related]
20. Potent organometallic osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in A549 non-small cell lung cancer cells.
van Rijt SH; Romero-Canelón I; Fu Y; Shnyder SD; Sadler PJ
Metallomics; 2014 May; 6(5):1014-22. PubMed ID: 24668459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
